CAS 57109-90-7

Clorazepato dipotássico

Descrição:

Clorazepato dipotássico é um derivado de benzodiazepina utilizado principalmente como medicamento ansiolítico e anticonvulsivante. É caracterizado pela sua capacidade de potencializar os efeitos do neurotransmissor ácido gama-aminobutírico (GABA) no receptor GABA-A, levando a propriedades sedativas, ansiolíticas, relaxantes musculares e anticonvulsivantes. A substância é tipicamente administrada em sua forma de sal dipotássico, que melhora sua solubilidade e biodisponibilidade. Clorazepato dipotássico é frequentemente prescrito para o tratamento de transtornos de ansiedade, sintomas de abstinência de álcool e certos tipos de convulsões. É importante notar que, assim como outras benzodiazepinas, pode levar à dependência e sintomas de abstinência após a interrupção após uso prolongado. Efeitos colaterais comuns podem incluir sonolência, tontura e comprometimento cognitivo. Devido ao seu potencial de abuso e dependência, Clorazepato dipotássico é classificado como uma substância controlada em muitas jurisdições, necessitando de monitoramento cuidadoso por profissionais de saúde durante o tratamento.

Fórmula: C₁₆H₁₁ClK₂N₂O₄

InChI: InChI=1S/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;;+1;/p-1

Chave InChI: InChIKey=TVVIGDFTYHGWSG-UHFFFAOYSA-M

SMILES: [K]O.C(O)(=O)C1N=C(C=2C(NC1=O)=CC=C(Cl)C2)C3=CC=CC=C3.[K]

Sinónimos:

• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (1:1)
• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1)
• 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt, compd. with potassium hydroxide (K(OH)) (1:1:1)
• 1H-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, hydroxide, potassium salt (1:1:2)
• 4306Cb
• 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid
• Ab 35616
• Abbott 35616
• Apo-Clorazepate
• Azene
• Belseren
• Bipotassium chlorazepate
• Cb 4306
• Chlorazepate
• Chlorazepate Dipotassium
• Chlorazepate dipotassic
• Clorazepate potassium
• Cm 4306
• Dikalium chlorazepate
• Dipotassium chlorazepate
• Dipotassium clorazepate
• Gen-xene
• Mendon
• Nevracten
• Novo-Clopate
• Nu-Clopate
• Potassium hydroxide (K(OH)), compd. with 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid monopotassium salt (1:1)
• Potassium hydroxide, compd. with 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid monopotassium salt (1:1)
• Tencilan
• Tr 19119
• Transene
• Tranxene
• Tranxilen
• Tranxilene
• Tranxilium
• Tranzene
• [2-Phenyl-2-(2-amino-5-chlorophenyl)-1-azavinyl]malonic acid
• potassium 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylate hydroxypotassium (1:1:1)

Clorazepate.dipotassium.monohydrate

Produto Controlado

CAS: 57109-90-7

Cor e Forma: Neat

Ref: LP-CLR-120-HY-10

Clorazepate Dipotassium

Produto Controlado

CAS: 57109-90-7

Applications Anxiolytic. Controlled substance (depressant).
References Cone, E., et al.: J. Pharm. Sci., 73, 243 (1984), Maurer, H., et al.: J. Anal. Toxicol., 25, 237 (2001), Beyer, J., et al.: Ther. Drug Monit., 27, 151 (2005),

Fórmula: C₁₆H₁₀ClN₂O₃·HKO·K

Cor e Forma: White To Light Yellow

Peso molecular: 408.92

Ref: TR-C587365

Clorazepate Dipotassium (1 mg/ml in Methanol)

Produto Controlado

CAS: 57109-90-7

Fórmula: C₁₆H₁₀ClN₂O₃·HKO·K

Cor e Forma: Colourless

Peso molecular: 408.92

Ref: TR-KIT4162

Clorazepic acid dipotasium salt

Produto Controlado

CAS: 57109-90-7

Please enquire for more information about Clorazepic acid dipotasium salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fórmula: C₁₆H₁₁ClK₂N₂O₄

Peso molecular: 408.92 g/mol

Ref: 3D-C-2990

Clorazepic acid dipotasium salt

Produto Controlado

CAS: 57109-90-7

Clorazepic acid dipotasium salt is a benzodiazepine with anticonvulsant and anxiolytic activity. It is metabolized to clorazepate, which has a longer half-life than the parent drug. Clorazepic acid dipotasium salt can be administered orally, intravenously, or intramuscularly. The drug is not active when taken orally and must be converted to clorazepate before it can exert its effects. Clorazepic acid dipotasium salt has been shown to have minimal toxicity in humans and animals. This drug has been shown to have a dose-dependent effect on δ receptors and serotonergic activity, but does not affect dopamine receptors or histamine H1 receptors. Clorazepic acid dipotasium salt binds to the benzodiazepine receptor site in the brain and decreases the frequency of seizures by inducing sedation

Fórmula: C₁₆H₁₁ClK₂N₂O₄

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 408.92 g/mol

Ref: 3D-FC20518

DIPOTASSIUM CLORAZEPATE MONOHYDRATE CRS - * PSY

Produto Controlado

CAS: 57109-90-7

DIPOTASSIUM CLORAZEPATE MONOHYDRATE CRS - * PSY

Ref: 41-Y0002276

Clorazepate Dipotassium CIV

Produto Controlado

CAS: 57109-90-7

Alprazolam(inn), camazepam (inn), chlordiazepoxide (inn), clonazepam (inn), clorazepate & other heterocyclic compounds with nitro atom(s) only

Fórmula: C₁₆H₁₁ClK₂N₂O₄

Cor e Forma: White Light Yellow Crystalline Powder

Peso molecular: 407.96815

Ref: 45-1140509